Stay updated on Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.

Latest updates to the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice and the v3.4.1 revision note; study content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedThe page now displays a government funding notice about potential delays and site operation status, and the revision badge was updated to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a 'Show glossary' option on the page; capitalization tweaks were applied to QC-related labels (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'). The revision was bumped from v3.3.4 to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page's changelog.SummaryDifference0.1%

- Check63 days agoChange DetectedLocations section added listing Arizona, California, New York, Ohio, Pennsylvania, and Texas sites. The page also shows a revision note indicating v3.3.3.SummaryDifference0.8%

- Check91 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2 with no visible changes to study content in the screenshots.SummaryDifference0.1%

Stay in the know with updates to Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral IMO-2125 in Refractory Solid Tumors Clinical Trial page.